Determinants of Dialysis Initiation
Dialysis should be initiated based on clinical symptoms and signs of uremia—not on GFR alone—with most patients starting when GFR falls below 10 mL/min/1.73 m², unless specific absolute indications mandate earlier intervention. 1, 2
GFR Thresholds: When to Consider Dialysis
The target GFR for dialysis initiation is approximately 10 mL/min/1.73 m², with conservative management continuing until GFR decreases below 15 mL/min/1.73 m² unless specific clinical indications exist. 1, 2 The National Kidney Foundation defines kidney failure as GFR <15 mL/min/1.73 m², which is accompanied in most cases by signs and symptoms of uremia, or a need to start kidney replacement therapy. 1
- Approximately 98% of patients with kidney failure in the United States begin dialysis when their GFR is less than 15 mL/min/1.73 m². 1
- The mean GFR at dialysis initiation is 9.8 mL/min/1.73 m², with lower values (7-9 mL/min/1.73 m²) for young and middle-aged adults and higher values (10-10.5 mL/min/1.73 m²) for children and elderly patients. 2
Critical Caveat: GFR Estimation Limitations
In patients with unusual creatinine generation (low muscle mass, malnutrition, elderly) or altered tubular secretion, measured GFR using 24-hour urine collection for creatinine and urea clearance is more accurate than estimated GFR. 3, 2 Serum creatinine-based eGFR may be misleading in individuals with advanced CKD, particularly the elderly or those with multiple comorbid conditions, due to dependence on creatinine generation from muscle mass. 1
Absolute Indications for Dialysis (Override GFR)
Dialysis must be initiated when any of the following are present, regardless of GFR level:
Uremic Symptoms
- Pericarditis (uremic pericarditis is an absolute indication) 3, 2
- Encephalopathy (altered mental status, asterixis, seizures attributable to uremia) 3, 2
- Intractable nausea/vomiting (refractory to antiemetic therapy) 3, 2
- Bleeding diathesis (uremic platelet dysfunction causing clinically significant bleeding) 3, 2
Volume and Hemodynamic Derangements
- Volume overload refractory to diuretic therapy (pulmonary edema, severe peripheral edema unresponsive to maximal diuretic doses) 3, 2
- Uncontrolled hypertension despite maximal medical management (three or more antihypertensive agents at optimal doses) 3, 2
Metabolic Derangements
- Hyperkalemia unresponsive to medical therapy (potassium >6.5 mEq/L despite dietary restriction, diuretics, and potassium binders) 3, 2
- Severe metabolic acidosis (pH <7.2 or bicarbonate <10 mEq/L refractory to oral alkali therapy) 3, 2
Nutritional Deterioration
- Protein-energy malnutrition that develops or persists despite vigorous nutritional intervention (declining edema-free body weight, falling serum albumin <4.0 g/dL, lean body mass <63%) 3, 2, 4
- Progressive deterioration in nutritional status with no apparent cause other than low nutrient intake 2
When Dialysis Can Be Safely Deferred
Dialysis may be safely deferred even when GFR <10 mL/min/1.73 m² if ALL of the following are present:
- Stable or increased edema-free body weight 2
- Adequate nutritional parameters (serum albumin ≥4.0 g/dL, stable lean body mass) 2, 4
- Complete absence of clinical signs or symptoms attributable to uremia 2
Additional Predictors of Earlier Dialysis Need
Certain predialysis characteristics predict patients who will require dialysis at higher GFR levels (≥7.8 mL/min/1.73 m²):
- Heart failure (adjusted odds ratio 3.68) 4
- Serum albumin <4.0 g/dL (adjusted odds ratio 2.22) 4
- BUN/creatinine ratio >15 mg/mg (adjusted odds ratio 1.92) 4
- Hyperuricemia (adjusted odds ratio 1.84) 4
For patients with these characteristics, clinicians should provide predialysis counseling in advance and consider early creation of vascular access to avoid unplanned urgent dialysis initiation. 4
Evidence Against Early Dialysis Initiation
There is no compelling evidence that initiation of dialysis based solely on measurement of kidney function leads to improvement in clinical outcomes, including overall mortality. 1 Multiple observational studies show that patients starting dialysis at higher GFR levels (>10 mL/min/1.73 m²) have higher mortality rates, though this reflects patient selection bias (sicker patients start earlier) rather than harm from early initiation per se. 1, 2
When corrected for lead-time bias, early dialysis initiation (eGFR >7.9 mL/min/1.73 m²) shows no survival benefit and may be associated with survival disadvantage. 5 The IDEAL trial found no signal of harm with initiation at higher GFR levels, but also no benefit, and most participants were healthier than typical dialysis patients. 1
Initial Dialysis Prescription: "Low and Slow" Approach
When dialysis is initiated, the first treatment must use a "low and slow" approach to minimize dialysis disequilibrium syndrome and hemodynamic instability:
- Initial session duration: 2-2.5 hours (not full 4 hours) 3, 2
- Reduced blood flow rates: 200-250 mL/min 3, 2
- Minimal ultrafiltration during first session, focusing on clearance rather than fluid removal 3, 2
- Frequent vital sign monitoring every 15-30 minutes during the first session, with close observation for neurological symptoms 3
- Gradual dose escalation over subsequent sessions as tolerated 3, 2
Critical Pitfalls to Avoid
Starting dialysis based on GFR alone in asymptomatic patients provides no survival benefit and may cause harm. 3, 2 Dialysis does not replace all kidney functions (tubular secretion, reabsorption, endocrine function) and provides only 10-20% of physiological clearance. 1
Hemodialysis-related hypotension may accelerate loss of residual kidney function, which is particularly problematic in patients who may recover renal function (such as those with AKI or chemotherapy-induced kidney injury). 3, 2 Residual kidney function is a major contributor to total urea and creatinine clearance and is a positive factor for patient outcomes. 6
Aggressive first dialysis sessions can cause cerebral edema, seizures, and cardiovascular instability due to rapid removal of uremic toxins. 3 Dialysis imposes significant burden on patients and families, with risks including vascular access complications and dialysate-related complications. 2
Clinical Decision Framework
The decision to initiate dialysis represents a compromise designed to maximize quality of life by extending the dialysis-free period while avoiding uremic complications. 2 This requires clinical judgment based on individual patient factors including age, comorbidities, vascular access status, transplant candidacy, and home dialysis eligibility. 2
In otherwise asymptomatic individuals, there is no reason to begin maintenance dialysis solely based on serum creatinine or eGFR value. 1 Rather, in patients with advanced CKD without clear uremic symptoms, efforts should be directed at preparing patients for a seamless and safe transition to kidney replacement therapy. 1